spacer
spacer
Go to PDB code: 
protein ligands metals links
Hydrolase PDB id
1ko3
Jmol
Contents
Protein chain
230 a.a. *
Ligands
ACT ×2
_OH
Metals
_ZN ×3
_CL
Waters ×136
* Residue conservation analysis
PDB id:
1ko3
Name: Hydrolase
Title: Vim-2, a zn-beta-lactamase from pseudomonas aeruginosa with cys221 reduced
Structure: Vim-2 metallo-beta-lactamase. Chain: a. Fragment: residues 30-295. Engineered: yes
Source: Pseudomonas aeruginosa. Organism_taxid: 287. Gene: blavim-2. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008.
Biol. unit: Tetramer (from PQS)
Resolution:
1.91Å     R-factor:   0.209     R-free:   0.250
Authors: I.Garcia-Saez,J.-D.Docquier,G.M.Rossolini,O.Dideberg
Key ref:
I.Garcia-Saez et al. (2008). The three-dimensional structure of VIM-2, a Zn-beta-lactamase from Pseudomonas aeruginosa in its reduced and oxidised form. J Mol Biol, 375, 604-611. PubMed id: 18061205 DOI: 10.1016/j.jmb.2007.11.012
Date:
20-Dec-01     Release date:   02-Sep-03    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
Q9K2N0  (Q9K2N0_PSEAE) -  Beta-lactamase class B VIM-2
Seq:
Struc:
266 a.a.
231 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Gene Ontology (GO) functional annotation 
  GO annot!
  Biochemical function     hydrolase activity     1 term  

 

 
DOI no: 10.1016/j.jmb.2007.11.012 J Mol Biol 375:604-611 (2008)
PubMed id: 18061205  
 
 
The three-dimensional structure of VIM-2, a Zn-beta-lactamase from Pseudomonas aeruginosa in its reduced and oxidised form.
I.Garcia-Saez, J.D.Docquier, G.M.Rossolini, O.Dideberg.
 
  ABSTRACT  
 
The crystal structures of the universally widespread metallo-beta-lactamase (MBL) Verona integron-encoded MBL (VIM)-2 from Pseudomonas aeruginosa have been solved in their native form as well as in an unexpected oxidised form. This carbapenem-hydrolysing enzyme belongs to the so-called B1 subfamily of MBLs and shares the folding of alpha beta/beta alpha sandwich, consisting of a core of beta-sheet surrounded by alpha-helices. Surprisingly, it showed a high tendency to be strongly oxidised at the catalytic cysteine located in the Cys site, Cys221, which, in the oxidised structure, becomes a cysteinesulfonic residue. Its native structure was obtained only in the presence of Tris(2-carboxyethyl)phosphine. This oxidation might be a consequence of a lower affinity for the second Zn located in the Cys site that would also explain the observed susceptibility of VIM-2 to chelating agents. This modification, if present in nature, might play a role in catalytic down-regulation. Comparison between native and oxidised VIM-2 and a predicted model of VIM-1 (which shows one residue different in the Cys site compared with VIM-2) is performed to explain the different activities and antibiotic specificities.
 
  Selected figure(s)  
 
Figure 2.
Fig. 2. Stereo view of the active site (His and Cys sites) of (a) VIM-2 and (b) oxidised VIM-2. Contacts between the Zn ions and Cys221 [in (a)] or Ocs221 [in (b)] with residues of the active site (< 3.5 Å) are depicted. Water molecules are shown as red spheres. The asterisk symbol indicates the position of the two residues in VIM-2 (Tyr224 and Arg228) that are different in VIM-1 (His224 and Ser228).
Figure 3.
Fig. 3. Secondary structure of VIM-2 (in orange) and sequence alignment with VIM-1 and VIM-3 variants. The residues labelled in black and green are the differences between VIM-2 and VIM-1 and between VIM-2 and VIM-3, respectively. Residues labelled in red belong to the His and Cys active sites. The asterisk symbol indicates the position of the two residues that are different in VIM-1 in comparison with VIM-2 in the Cys site.
 
  The above figures are reprinted by permission from Elsevier: J Mol Biol (2008, 375, 604-611) copyright 2008.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
20961909 M.Castanheira, L.M.Deshpande, R.E.Mendes, E.Rodriguez-Noriega, R.N.Jones, and R.Morfin-Otero (2011).
Comment on: Role of changes in the L3 loop of the active site in the evolution of enzymatic activity of VIM-type metallo-{beta}-lactamases.
  J Antimicrob Chemother, 66, 684-685.  
19901092 F.Robin, N.Aggoune-Khinache, J.Delmas, M.Naim, and R.Bonnet (2010).
Novel VIM metallo-beta-lactamase variant from clinical isolates of Enterobacteriaceae from Algeria.
  Antimicrob Agents Chemother, 54, 466-470.  
19917750 J.M.Rodriguez-Martinez, P.Nordmann, N.Fortineau, and L.Poirel (2010).
VIM-19, a metallo-beta-lactamase with increased carbapenemase activity from Escherichia coli and Klebsiella pneumoniae.
  Antimicrob Agents Chemother, 54, 471-476.  
20498317 L.Borgianni, J.Vandenameele, A.Matagne, L.Bini, R.A.Bonomo, J.M.Frère, G.M.Rossolini, and J.D.Docquier (2010).
Mutational analysis of VIM-2 reveals an essential determinant for metallo-beta-lactamase stability and folding.
  Antimicrob Agents Chemother, 54, 3197-3204.  
20624761 M.Merino, F.J.Pérez-Llarena, F.Kerff, M.Poza, S.Mallo, S.Rumbo-Feal, A.Beceiro, C.Juan, A.Oliver, and G.Bou (2010).
Role of changes in the L3 loop of the active site in the evolution of enzymatic activity of VIM-type metallo-beta-lactamases.
  J Antimicrob Chemother, 65, 1950-1954.  
20121112 P.Oelschlaeger, N.Ai, K.T.Duprez, W.J.Welsh, and J.H.Toney (2010).
Evolving carbapenemases: can medicinal chemists advance one step ahead of the coming storm?
  J Med Chem, 53, 3013-3027.  
20305272 Y.Yamaguchi, N.Takashio, J.Wachino, Y.Yamagata, Y.Arakawa, K.Matsuda, and H.Kurosaki (2010).
Structure of metallo-beta-lactamase IND-7 from a Chryseobacterium indologenes clinical isolate at 1.65-A resolution.
  J Biochem, 147, 905-915.
PDB code: 3l6n
19651913 C.Bebrone, H.Delbrück, M.B.Kupper, P.Schlömer, C.Willmann, J.M.Frère, R.Fischer, M.Galleni, and K.M.Hoffmann (2009).
The structure of the dizinc subclass B2 metallo-beta-lactamase CphA reveals that the second inhibitory zinc ion binds in the histidine site.
  Antimicrob Agents Chemother, 53, 4464-4471.
PDB codes: 3f9o 3fai
19553129 D.Minond, S.A.Saldanha, P.Subramaniam, M.Spaargaren, T.Spicer, J.R.Fotsing, T.Weide, V.V.Fokin, K.B.Sharpless, M.Galleni, C.Bebrone, P.Lassaux, and P.Hodder (2009).
Inhibitors of VIM-2 by screening pharmacologically active and click-chemistry compound libraries.
  Bioorg Med Chem, 17, 5027-5037.  
19770275 D.Yong, M.A.Toleman, C.G.Giske, H.S.Cho, K.Sundman, K.Lee, and T.R.Walsh (2009).
Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India.
  Antimicrob Agents Chemother, 53, 5046-5054.  
18519714 I.Schneider, E.Keuleyan, R.Rasshofer, R.Markovska, A.M.Queenan, and A.Bauernfeind (2008).
VIM-15 and VIM-16, two new VIM-2-like metallo-beta-lactamases in Pseudomonas aeruginosa isolates from Bulgaria and Germany.
  Antimicrob Agents Chemother, 52, 2977-2979.  
18362187 P.Marchiaro, P.E.Tomatis, M.A.Mussi, F.Pasteran, A.M.Viale, A.S.Limansky, and A.J.Vila (2008).
Biochemical characterization of metallo-beta-lactamase VIM-11 from a Pseudomonas aeruginosa clinical strain.
  Antimicrob Agents Chemother, 52, 2250-2252.  
18559652 Ã.˜.Samuelsen, M.Castanheira, T.R.Walsh, and J.Spencer (2008).
Kinetic characterization of VIM-7, a divergent member of the VIM metallo-beta-lactamase family.
  Antimicrob Agents Chemother, 52, 2905-2908.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.